Amgen Inc
Nasdaq · Healthcare · Biological Products, (No Diagnostic Substances) · Thousand Oaks, CA
AMGN chart
What traders are saying about $AMGN
Latest postsAmgen Inc news
- Gene Therapy - Global Strategic Business Report: Capitalize on 23% CAGR as the Market Hits US$6 Billion by 2030; Benchmark Amgen, Alnylam, BioMarin, Biogen and bluebird bio
Yahoo Finance ·
- Want $7,000 in Passive Income? Buy These 3 Dividend Stocks Today
247wallst.com ·
- Amgen reports positive phase 3 trial results for Sjögren’s treatment
Investing.com ·
- Amgen's experimental Sjogren's drug meets late-stage trial goal
Reuters ·
- Amgen, In A Buy Zone, Unveils Highly Anticipated Novartis-Rivaling Sjogren's Data
Yahoo Finance ·
- AMGEN ANNOUNCES POSITIVE PHASE 3 RESULTS FOR DAZODALIBEP IN SJÖGREN'S DISEASE
Yahoo Finance ·
- Six Flags Names Adam Boal Chief Procurement Officer
Yahoo Finance ·
- Amgen builds Sjögren’s case with detailed phase 3 data ahead of Novartis showdown
Fierce Biotech ·
- How Amgen, In A Buy Zone, Is Taking On Novartis With A First-Ever
Investor's Business Daily ·
- Amgen stock: ACR abstract details dazodalibep Phase 3 results
ad-hoc-news.de ·
- iShares Biotechnology ETF (IBB) Adds Gilead and Amgen on Nov. 9
Yahoo Finance ·
- Spdr Dow Jones Industrial Average ETF (DIA) Buys $40.3 Million More GS on Nov. 9
Yahoo Finance ·
Amgen Inc key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $36.75B | $33.42B | $28.19B | $26.32B |
| Net income | $7.71B | $4.09B | $6.72B | $6.55B |
| Diluted EPS | $14.23 | $7.56 | $12.49 | $12.11 |
| Total assets (year end) | $90.59B | $91.84B | $97.15B | $65.12B |
| Cash and equivalents (year end) | $9.13B | $11.97B | $10.94B | $7.63B |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Amgen Inc
- Ticker
- AMGN (Nasdaq)
- Industry
- Biological Products, (No Diagnostic Substances)
- Headquarters
- Thousand Oaks, CA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 318154
Frequently asked questions
What exchange is Amgen Inc listed on?
Amgen Inc trades on the Nasdaq under the ticker symbol AMGN.
What industry is Amgen Inc in?
Amgen Inc is classified by the SEC under "Biological Products, (No Diagnostic Substances)", part of the Healthcare sector on StockTweeting.
Where is Amgen Inc headquartered?
Amgen Inc's business address on file with the SEC is in Thousand Oaks, CA.
When does Amgen Inc's fiscal year end?
Amgen Inc's fiscal year ends on December 31.
How much revenue did Amgen Inc report?
Amgen Inc reported $36.75B in revenue for calendar year 2025, according to its SEC filings.